Paul Hastings Advised Pactiv Evergreen Inc. in Its $6.7 Billion Combination With Novolex
December 10, 2024
December 10, 2024
LOS ANGELES, California, Dec. 10 -- Paul Hastings, a law firm, issued the following news:
Paul Hastings LLP advised Pactiv Evergreen Inc. (NASDAQ: PTVE) in its combination with Novolex. Under the terms of the agreement, Novolex will acquire Pactiv Evergreen for $18.00 per share in an all-cash transaction valued at $6.7 billion, inclusive of Pactiv Evergreen's net debt. Upon the completion of the transaction, Pactiv Evergreen will become a privately held company.
Pactiv . . .
Paul Hastings LLP advised Pactiv Evergreen Inc. (NASDAQ: PTVE) in its combination with Novolex. Under the terms of the agreement, Novolex will acquire Pactiv Evergreen for $18.00 per share in an all-cash transaction valued at $6.7 billion, inclusive of Pactiv Evergreen's net debt. Upon the completion of the transaction, Pactiv Evergreen will become a privately held company.
Pactiv . . .